HPS Pharmacies wish to give notice that Pfizer Australia Pty Ltd are currently experiencing an interruption to the supply of Nimenrix® vaccine as follows:
Nimenrix® Injection Vial and Diluent Syringe
Meningococcal polysaccharide serogroups A, C, W-135, and Y conjugate
This supply interruption in the private market is due to prioritisation of doses for targeted public health programs in Western Australia and South Australia. Normal supplies are expected to resume in mid May 2017.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer Australia on (02) 9850 3333.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.